Sarepta Therapeutics, Inc. (BMV:SRPT)
Mexico · Delayed Price · Currency is MXN 411.00
-19.00 (-4.42%)
At close: Oct 10, 2025
Sarepta Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Net Income | -57.96 | 235.24 | -535.98 | -703.49 | -418.78 | -554.13 | Upgrade |
Depreciation & Amortization | 41.11 | 37.75 | 44.4 | 41.86 | 38.02 | 26.91 | Upgrade |
Stock-Based Compensation | 171.58 | 184.3 | 182.51 | 233.02 | 113.94 | 108.07 | Upgrade |
Other Adjustments | -18.28 | 33.55 | 201.41 | 146.23 | -78.19 | -29.46 | Upgrade |
Change in Receivables | -247.3 | -281.66 | -185.69 | -61.64 | -51.65 | -10.46 | Upgrade |
Changes in Inventories | -468.75 | -395.17 | -147.71 | -50.78 | -83.77 | -60.58 | Upgrade |
Changes in Accounts Payable | 83.73 | 110.65 | -50.14 | 147.57 | 23.3 | 42 | Upgrade |
Changes in Unearned Revenue | -51.61 | -32.16 | -86.83 | -89.24 | -89.24 | 749.43 | Upgrade |
Changes in Other Operating Activities | 34.06 | -194.26 | -10.71 | 15 | 103.2 | -166.33 | Upgrade |
Operating Cash Flow | -380.75 | -285.79 | -500.99 | -325.35 | -443.17 | 107.47 | Upgrade |
Capital Expenditures | -150.79 | -136.96 | -76.11 | -30.82 | -38.49 | -82.2 | Upgrade |
Purchases of Intangible Assets | - | -10 | -11.24 | -1.43 | -2.31 | - | Upgrade |
Proceeds from Sale of Intangible Assets | - | - | 102 | - | 102 | 108.07 | Upgrade |
Purchases of Investments | - | -1,100 | -2,049 | -1,938 | -31.79 | -1,334 | Upgrade |
Proceeds from Sale of Investments | 1,372 | 2,002 | 1,864 | 923.22 | 466 | 1,189 | Upgrade |
Other Investing Activities | - | - | - | - | - | -3.5 | Upgrade |
Investing Cash Flow | 376.33 | 755.56 | -165.8 | -1,047 | 495.41 | -121.72 | Upgrade |
Long-Term Debt Issued | - | - | - | 1,127 | - | 291.15 | Upgrade |
Long-Term Debt Repaid | - | -0.07 | - | -823.23 | - | - | Upgrade |
Net Long-Term Debt Issued (Repaid) | - | -0.07 | - | 304.17 | - | 291.15 | Upgrade |
Issuance of Common Stock | 34.65 | 79.53 | 51.25 | 30.04 | 569.33 | 396.01 | Upgrade |
Net Common Stock Issued (Repurchased) | 34.65 | 79.53 | 51.25 | 30.04 | 569.33 | 396.01 | Upgrade |
Other Financing Activities | - | 45.35 | 73.76 | -101.7 | -7.77 | -4.84 | Upgrade |
Financing Cash Flow | 51.4 | 124.81 | 125 | 232.51 | 561.57 | 682.32 | Upgrade |
Net Cash Flow | 126.98 | 674.58 | -541.79 | -1,140 | 613.81 | 668.07 | Upgrade |
Beginning Cash & Cash Equivalents | 399.2 | 444.01 | 985.8 | 2,126 | 1,512 | 843.65 | Upgrade |
Ending Cash & Cash Equivalents | 526.18 | 1,119 | 444.01 | 985.8 | 2,126 | 1,512 | Upgrade |
Free Cash Flow | -531.55 | -422.74 | -577.1 | -356.17 | -481.66 | 25.26 | Upgrade |
FCF Margin | -21.42% | -22.23% | -46.42% | -38.17% | -68.62% | 4.68% | Upgrade |
Free Cash Flow Per Share | -4.86 | -3.92 | -6.25 | -4.07 | -5.93 | 0.32 | Upgrade |
Levered Free Cash Flow | -570.2 | -374.98 | -863.08 | -365.73 | -465.77 | 246.25 | Upgrade |
Unlevered Free Cash Flow | -514.48 | -413.42 | -603.1 | -513.12 | -506.51 | -56.02 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.